Vylor Targets $500M Incremental Revenue by 2035 with Four New Soybean Tech Platforms
CTVA sits 36% above its 52-week low of $60.535.
Summary
Corteva's seed spin-off Vylor unveiled a soybean technology roadmap ahead of its October 1 separation, planning four new platforms by 2035 that it expects to generate ~$500M in incremental revenue. The strategy includes next-gen herbicide tolerance in North America and a proprietary broad-spectrum insect control platform for Latin America, plus two industry firsts targeting Asian Soybean Rust and multi-disease resistance. This is the first detailed product pipeline disclosure for Vylor and gives investors a concrete growth framework for the standalone company. The $500M revenue target by 2035 is a long-dated but material figure that frames Vylor's post-spin value proposition. Watch for further details on licensing economics and launch timelines as the separation completes.
At the time of this announcement, CTVA was trading at $82.55 on NYSE in the Life Sciences sector, with a market capitalization of approximately $55.1B. The 52-week trading range was $60.54 to $90.97. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: PR Newswire.